HCPCS J-code
J2350: ocrelizumab
Ocrelizumab 1 mg (MS)
Code
J2350
Generic
ocrelizumab
Brands
Ocrevus
Drug class
Biologic drugs (mAbs and biosimilars)
Common denial patterns
- MS diagnosis confirmation
- Step therapy with other DMTs
- Site-of-care reduction
Frequently asked questions
What is HCPCS J2350?
Ocrelizumab 1 mg (MS)
Why does insurance commonly deny J2350?
MS diagnosis confirmation; Step therapy with other DMTs; Site-of-care reduction.
What brand-name drug uses J2350?
Ocrevus.
Related
Appeal a J2350 denial
Upload the denial — we draft the appeal letter in 5 minutes citing the right clinical guideline.
Get started →Contact: hello@approvalhelp.com